Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Return on Assets: 2024-2025

Historic Return on Assets for Inhibrx Biosciences (INBX) over the last 1 years, with Sep 2025 value amounting to -0.80%.

  • Inhibrx Biosciences' Return on Assets fell 763.00% to -0.80% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.80%, marking a year-over-year decrease of 763.00%. This contributed to the annual value of 6.91% for FY2024, which is N/A change from last year.
  • Inhibrx Biosciences' Return on Assets amounted to -0.80% in Q3 2025, which was down 10.59% from -0.72% recorded in Q2 2025.
  • In the past 5 years, Inhibrx Biosciences' Return on Assets registered a high of 8.37% during Q4 2024, and its lowest value of -0.80% during Q3 2025.
  • Over the past 2 years, Inhibrx Biosciences' median Return on Assets value was 6.83% (recorded in 2024), while the average stood at 4.36%.
  • Data for Inhibrx Biosciences' Return on Assets shows a maximum YoY slumped of 763bps (in 2025) over the last 5 years.
  • Inhibrx Biosciences' Return on Assets (Quarterly) stood at 8.37% in 2024, then slumped by 763bps to -0.80% in 2025.
  • Its Return on Assets was -0.80% in Q3 2025, compared to -0.72% in Q2 2025 and 8.14% in Q1 2025.